Icatibant Acetate is Used for treating acute attacks of hereditary angioedema by antagonizing bradykinin receptor. It was first introduced by Takeda Pharmaceuticals Usa Inc in its drug Firazyr on Aug 25, 2011. 11 different companies have introduced drugs containing Icatibant Acetate.
Icatibant Acetate Patents
Given below is the list of patents protecting Icatibant Acetate, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Icatibant Acetate Generic API Manufacturers
Several generic applications have been filed for Icatibant Acetate. The first generic version for Icatibant Acetate was by Teva Pharmaceuticals Usa Inc and was approved on Jul 15, 2019. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Jun 14, 2024.
Given below is the list of companies who have filed for
Icatibant Acetate generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Icatibant Acetate. Given below are the
details of the strengths of this generic introduced by
Alembic.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
injectable
Prescription
SUBCUTANEOUS
AP
Jun 14, 2024
Manufacturing Plant Locations
New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Caplin Steriles Ltd has filed for 1 generic for Icatibant Acetate. Given below are the
details of the strengths of this generic introduced by
Caplin.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
injectable
Discontinued
SUBCUTANEOUS
N/A
Oct 5, 2020
Manufacturing Plant Locations
New
Caplin's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Caplin as present at those locations.
Country
City
Firm Name
United States
Creve Coeur
Caplin, Dr David
India
Gummidipoondi
Caplin Steriles Limited
3. CIPLA
Cipla Ltd has filed for 1 generic for Icatibant Acetate. Given below are the
details of the strengths of this generic introduced by
Cipla.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
injectable
Prescription
SUBCUTANEOUS
AP
Jul 13, 2020
Manufacturing Plant Locations
New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
Country
City
Firm Name
India
Pithampur, District Dhar
Cipla Limited
Kurkumbh Village, Dist. Pune
Cipla, Ltd.
Bengaluru
Cipla Limited
Raigad
Cipla Limited
Vasco Da Gama
Cipla Limited
Bangalore
Cipla Ltd.
Mumbai
Cipla Limited
4. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Icatibant Acetate. Given below are the
details of the strengths of this generic introduced by
Eugia Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
injectable
Prescription
SUBCUTANEOUS
AP
Aug 14, 2023
Manufacturing Plant Locations
New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
Country
City
Firm Name
India
Riico Industrial Area
EUGIA Pharma Specialities Limited
Pashamylaram
Eugia Pharma Specialities Limited
Medchal-Malkajgiri District
EUGIA Pharma Specialities Limited
5. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 1 generic for Icatibant Acetate. Given below are the
details of the strengths of this generic introduced by
Fresenius Kabi Usa.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
injectable
Prescription
SUBCUTANEOUS
AP
Jun 18, 2020
Manufacturing Plant Locations
New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
Country
City
Firm Name
United States
Melrose Park
Fresenius Kabi USA LLC
Bensenville
Fresenius Kabi USA LLC (FK USA)
Lake Zurich
Fresenius Kabi USA, LLC
Grand Island
Fresenius Kabi USA, LLC
Melrose Park
Fresenius Kabi USA, LLC
Wilson
Fresenius Kabi USA, LLC
North Andover
Fresenius Kabi USA, LLC
Skokie
Fresenius Kabi USA LLC
6. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Icatibant Acetate. Given below are the
details of the strengths of this generic introduced by
Glenmark Pharms Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
injectable
Discontinued
SUBCUTANEOUS
N/A
May 21, 2021
7. JIANGSU HANSOH PHARM
Jiangsu Hansoh Pharmaceutical Group Co Ltd has filed for 1 generic for Icatibant Acetate. Given below are the
details of the strengths of this generic introduced by
Jiangsu Hansoh Pharm.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
injectable
Prescription
SUBCUTANEOUS
AP
Mar 9, 2020
Manufacturing Plant Locations
New
Jiangsu Hansoh Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Jiangsu Hansoh Pharm as present at those locations.
Country
City
Firm Name
China
Lianyungang
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Lianyungang
Jiangsu Hansoh Pharmaceutical Group Co., Ltd
8. NANG KUANG PHARM CO
Nang Kuang Pharmaceutical Co Ltd has filed for 1 generic for Icatibant Acetate. Given below are the
details of the strengths of this generic introduced by
Nang Kuang Pharm Co.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
injectable
Prescription
SUBCUTANEOUS
AP
Dec 16, 2020
9. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Icatibant Acetate. Given below are the
details of the strengths of this generic introduced by
Teva Pharms Usa.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
injectable
Prescription
SUBCUTANEOUS
AP
Jul 15, 2019
10. WILSHIRE PHARMS INC
Wilshire Pharmaceuticals Inc has filed for 1 generic for Icatibant Acetate. Given below are the
details of the strengths of this generic introduced by
Wilshire Pharms Inc.
